Pfizer’s Paxlovid and Merck & Co’s Molnupiravir are two oral antiviral treatments authorised for patients with mild to moderate COVID-19 symptoms at a high risk of developing severe illness.
The "Antiviral Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. The global antiviral drugs market is forecasted ...
Antiviral drugs can be used for the treatment of influenza and the prevention of seasonal and post-exposure influenza. Four antiviral drugs are available for the prevention and treatment of ...